Cited by 88Cancer survivorship and careSleep and related disordersColorectal Cancer Treatments and Studies

Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer

Innominato, Pasquale F., Spiegel, David, Ulusakarya, Ayhan, Giacchetti, Sylvie, Bjarnason, Georg A., Lévi, Francis, Palesh, Oxana·2015·Sleep Medicine

Abstract

Backround Sleep disorders are prevalent in patients with advanced cancer. Their impact on clinical outcomes is not well understood.Methods A post-hoc analysis was conducted in 361 chemo-naïve patients with metastatic colorectal cancer completing twice the EORTC QLQ-C30 questionnaire within a randomized international phase III trial. The study assessed the effect on overall survival (OS) of subjective sleep complaint, used as a normal or a time-dependent covariate (TDC), using a multivariate Cox proportional hazard model. Prognostic analysis was conducted on the whole study population and separately in each treatment arm (conventional FOLFOX2, or chronomodulated chronoFLO4).Results Sleep problems were reported by 202 patients (56%) at baseline and by 188 (52%) on treatment. Sleep problems at baseline were independently associated with a higher risk of earlier death (HR: 1.36; p = 0.011), progression (HR: 1.43; p = 0.002) and poor treatment response (RR: 0.58; p = 0.016). TDC analysis confirmed the independent prognostic effect of sleep problems on OS (HR: 1.37; p = 0.008), while on treatment this effect was only observed using univariate analysis. The negative prognostic value of sleep problems on OS at baseline, on treatment, and as a TDC was greatest on chronoFLO4 compared to FOLFOX2.Conclusions Subjective sleep problems are associated with poor clinical outcomes in metastatic colorectal cancer patients and affect chronotherapy effectiveness. There is a need for a well-tuned circadian timing system in order to increase chronotherapy activity. Prospective studies are needed for determining the impact of therapeutic approaches on sleep disorders upon quality of life and survival of cancer patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sleep.2014.10.022

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Untreated cancer-related insomnia may contribute to poorer treatment response, increased risk of cancer recurrence, and reduced survival.

    “Untread cancer-related insomnia may also contribute to poorer treatment response, increased risk of cancer recurrence, and reduced survival. 9-11”

    From Digital Cognitive-Behavioral Therapy for Insomnia in Cancer Survivors: Protocol for a Pragmatic Clinical Trial (2024) · cites this paper as [9]

    The Results section (page not supplied) links baseline sleep complaints in patients with metastatic colorectal cancer to lower objective response, earlier disease progression, and shorter survival. It does not assess cancer recurrence or establish that the sleep problems were untreated insomnia. The reported associations also do not establish that insomnia caused the poorer outcomes. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]1. Palesh O, Peppone L, Innominato PF, et al. Prevalence, Putative Mechanisms and Management of Sleep Problems During Chemotherapy. Nature and Science of Sleep. 2012;4: 151162.

Cited by

Sorted by citations

Authors
Innominato, P. F., Spiegel, D., Ulusakarya, A., Giacchetti, S., Bjarnason, G. A., Lévi, F., & Palesh, O.
Affiliations
  • Inserm (FR)
  • Stanford Medicine (US)
  • Sunnybrook Health Science Centre (CA)
Corresponding author
Innominato, Pasquale F.
Venue
Sleep Medicine
Publisher
Elsevier BV
Published
2015-03
Volume
16
Issue
3
Pages
391-398
ISSN
1389-9457 (ISSN-L)
OpenAlex
W2067058194
Cited by
88
References
40
Citations by year
2026: 5 · 2025: 10 · 2024: 14 · 2023: 7 · 2022: 9 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 1 · 2014: 1
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Locations
  • Sleep Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
Funders
Association Internationale pour la Recherche sur le Temps Biologique et la Chronotherapie (ARTBC International), Paul Brousse Hospital, Villejuif, France
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
sleep disorders, metastatic colorectal cancer, subjective sleep complaints, overall survival, prognostic factors, chronotherapy, chemotherapy-naive patients, circadian timing, EORTC QLQ-C30
MeSH terms
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Leucovorin, Female, Fluorouracil, Humans, Male, Middle Aged, Organoplatinum Compounds, Prognosis, Quality of Life, Surveys and Questionnaires, Sleep Wake Disorders, Colorectal Neoplasms, Survival Rate, Proportional Hazards Models, Chronotherapy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review